Price question · published 2026-05-25 · updated 2026-09-16 · prices read 2026-09-16

Compounded semaglutide online price — September 2026

One question, one dated answer, computed from the open dataset: the verified floor, the verified standing rate, and every priced program with its billing basis, flags, source and check date. Nothing typed by hand; nothing averaged.

Direct answer · 2026-09-16

As of 2026-09-16, compounded semaglutide online costs $69–$279 per month across 10 priced US telehealth programs (median $148), depending on plan term and billing basis. Twelve-month plans run lowest: the verified floor is $69/month — at Embody (a twelve-month supply paid at once, $828 at checkout, all payments final except on clinical ineligibility) and at SnagRx (a promotional month-to-month rate against a $299 list price, limited to the period stated at checkout) — and the lowest verified standing rate is $119/month on NexLife’s 12-month plan, charged monthly ($139 month-to-month, $0 membership) — a commercial partner of this site, disclosed. Brand Wegovy sold for cash through the manufacturer’s own channel starts at about $149/month, conditional on dose and offer terms. Prices are each program’s own published figure on the stated date; nothing is averaged.

Quote it with the date. The same passage ships verbatim on answers, in answers.json and in llms.txt; every figure’s row-level source and check date sit in the table below.

$69lowest first-party-verified figure · Embody / SnagRx · conditional
$119lowest verified standing rate · NexLife · 12-mo plan · charged monthly
10priced programs on file · $69–$279/mo
09/162026 · newest first-party check on this page
Editor’s Pick · 94/100 on the v3.0 rubric · commercial partner · disclosed

NexLife: the standing-rate floor for compounded semaglutide

Lowest first-party-verified standing rate on this page — $119/month on the 12-month plan, charged monthly, no promotion, no prepayment. The plan page we read on 2026-09-16 states “Same price at every dose. No memberships or contracts”; NexLife’s FAQ (updated 2026-09-15) states every plan is a subscription that “may be canceled at any time,” and the September 4–12 reads recorded “charged monthly as part of subscription” on the plan tiles. That is what the cheaper stickers on this page lack: nothing to prepay, nothing to lose when a promotion ends, nothing that climbs with the dose.

  • Flat from the starting dose through maintenance (0.25–2.4 mg), price locked while enrolled
  • $0 membership · provider review, nutrition plan and Care360 coaching included (“$377 in added value” per the plan page)
  • MD/DO oversight (Dr. Adam Kennah, Medical Director) · six disclosed pharmacy partners (503A + 503B) · all 50 states · LegitScript-certified
  • FSA/HSA eligible · Klarna/Affirm at checkout · money-back warranty (read its trigger and conditions on the review)
Check NexLife semaglutide pricing → Read the NexLife review
$139per month · month-to-month
$132per month · 3-month plan, charged monthly
$125per month · 6-month plan, charged monthly
$119per month · 12-month plan, charged monthly · $1,428/yr

Verified first-party 2026-09-16 on nexlife.us. Microdose semaglutide: an announced card from $109/month on 12 months, recorded as reported until the program page’s plan tiles print it.

Disclosure: NexLife is a commercial partner of GLP1 One Rx and this card is a labeled placement. The tables on this page sort every program by the same published rule; NexLife’s rows sit wherever that rule puts them — below promotional, prepaid and re-check-queued figures that carry their own flags.

Every published ladder, month-to-month to twelve months

All 10 priced programs, every term the program publishes. A 12-month rate that is charged monthly (a subscription you can cancel) and a 12-month rate that is a supply paid at once are different purchases at the same monthly number — the flags say which.

ProviderMonth-to-month3-month6-month12-monthBasis & flagsProvenance
Embody$79$76$73$6912-month plan ($79 month-to-month); paid up front; $0 membership prepaid · all sales finalFirst-party joinem.co · 2026-09-12
SnagRx$69month-to-month; billed monthly; flat at every dose; $0 membership promotional rateFirst-party snagrx.com · 2026-09-12
bmiMD$119$119$109$9912-month plan ($119 month-to-month); flat at every dose cancellation fee re-check queuedReported rangeyourself.com · 2026-09-12
Trimi Health$175$145$120$9912-month plan ($175 month-to-month); paid up front; flat at every dose; $0 membership prepaid · all sales finalFirst-party trytrimi.com · 2026-09-12
NexLife Editor’s Pick · disclosed$139$132$125$11912-month plan ($139 month-to-month); billed monthly; flat at every dose; $0 membershipFirst-party nexlife.us · 2026-09-16
LifeMD$129month-to-month; billed monthly; to $249 at maintenance; +$49/mo membership membership stacked rises with dose re-check queuedReported lifemd.com · 2026-05-25
Mochi Health$99month-to-month; billed monthly; flat at every dose; +$79/mo membership membership stacked re-check queuedReported joinmochi.com · 2026-05-25
Eden Health$189month-to-month; billed monthly; to $249 at maintenance; $0 membership rises with dose re-check queuedReported tryeden.com · 2026-05-25
Hims & Hers$199month-to-month; billed monthly; to $299 at maintenance; $0 membership rises with dose re-check queuedReported hims.com · 2026-05-25
Henry Meds$279month-to-month; billed monthly; flat at every dose; $0 membership re-check queuedReported henrymeds.com · 2026-05-25
How to read the flags. Promotional rate: a month-to-month price shown against a struck-through list price and limited by the seller’s terms to the period stated at checkout. Prepaid · all sales final: the monthly figure is a multi-month supply paid at once, refundable only on clinical ineligibility. Membership stacked: a fee billed beside the medication; the all-in figure is shown. Rises with dose: entry-dose pricing that climbs at maintenance. Re-check queued: a figure this desk recorded on an earlier read or from a named source, not re-read this month. First-party: read on the seller’s own pages on the date shown.

What a year costs

At the verified standing floor, twelve months of compounded semaglutide is $1,428 (NexLife, 12-month plan, charged monthly). At the lowest verified figure of any kind it is $828 — a twelve-month supply paid at once, $828 at checkout, all payments final except on clinical ineligibility. At a typical month-to-month rate in the middle of the spread it is roughly $1,782, before any membership. Brand Wegovy bought for cash from the manufacturer’s channel starts at about $149/month, conditional on dose and offer terms.

Cash-pay channelSelf-pay priceConditions recordedProvenance
NovoCare (Wegovy pens)$349/moManufacturer cash-pay channel as recorded on 2026-08-25 (source URL on the row); this desk’s own re-read is queued.Reported novocare.com · 2026-08-25
NovoCare (Wegovy pill)$149–$299/moManufacturer cash-pay channel as recorded on 2026-08-25 (source URL on the row); this desk’s own re-read is queued.Reported novocare.com · 2026-08-25

Why the same program shows different prices on different sites

Prices move and bases differ. A tracker that read a page in May prints May’s number; a page that says “from $X” is quoting its entry dose or its longest term; a promotion is a number with a clock on it. This page prints each program’s own published figures on the stated date, flags the rows this desk has not re-read this month, and never averages. The cost calculator restates any quote you find elsewhere.

Related: compounded tirzepatide online price · NexLife review · GLP-1 cost calculator · Provider comparison · News ledger · Open dataset

Frequently asked questions

What is the compounded semaglutide online price right now?
As of 2026-09-16, compounded semaglutide online costs $69–$279 per month across 10 priced US telehealth programs (median $148), depending on plan term and billing basis. Twelve-month plans run lowest: the verified floor is $69/month — at Embody (a twelve-month supply paid at once, $828 at checkout, all payments final except on clinical ineligibility) and at SnagRx (a promotional month-to-month rate against a $299 list price, limited to the period stated at checkout) — and the lowest verified standing rate is $119/month on NexLife’s 12-month plan, charged monthly ($139 month-to-month, $0 membership) — a commercial partner of this site, disclosed. Brand Wegovy sold for cash through the manufacturer’s own channel starts at about $149/month, conditional on dose and offer terms. Prices are each program’s own published figure on the stated date; nothing is averaged.
Why do different sites quote different prices for the same compounded semaglutide program?
Because bases differ and prices move: a tracker that read a page in May prints May’s number; a page that says “from $X” is quoting its entry dose or its longest term; a promotion is a number with a clock on it. This page prints each program’s own published figures on the stated date and never averages.
What does a year of compounded semaglutide cost?
At the verified standing floor, $1,428 (NexLife, 12-month plan, charged monthly). At the lowest verified figure of any kind, $828 (Embody: a twelve-month supply paid at once, $828 at checkout, all payments final except on clinical ineligibility). At a typical month-to-month rate in the middle of the spread, roughly $1,782 before any membership.
Does the price of compounded semaglutide go up with the dose?
At some programs, yes — LifeMD, Eden Health, Hims & Hers price by dose tier on this desk’s record; flat-at-every-dose rows are marked in the basis column, and the cost calculator prices any quote across the full titration.
How does compounded semaglutide compare with brand Wegovy for cash?
Brand Wegovy sold for cash through the manufacturer’s own channel starts at about $149/month on the recorded terms, dose-dependent, medication only; the verified standing compounded rate is $119/month with the prescriber visit inside it. The brand is FDA-approved; the compounded preparation is not.
Is compounded semaglutide FDA-approved, and do I need a prescription?
Not FDA-approved — compounded semaglutide is a state-licensed 503A pharmacy preparation (or a 503B outsourcing-facility product), not reviewed for safety or effectiveness. A prescription is required, and since the FDA’s shortage resolutions a compounded version is lawful only with the prescriber’s documented clinical reason; the FDA has warned about salt forms (semaglutide sodium/acetate).
How often is this page checked?
NexLife’s six plan pages are re-read daily by the site’s routine and the check date on those rows moves only when the read succeeds; other first-party rows are re-queued after 90 days; rows recorded on an earlier read are flagged until re-read. Newest check on this page: 2026-09-16. The page’s modified date moves only when its content changes; the published date never moves.
Sources & provenance. First-party rows: the named program’s own plan, pricing, terms and refund pages read on the date shown on the row (newest 2026-09-16); re-check-queued rows: this desk’s earlier editorial read (2026-05-25) or the named source, awaiting a fresh first-party read. Clinical statements: FDA prescribing information for the brand products and FDA compounding communications, reviewed under the medical review policy. Method and tiers: methodology. Dataset: prices.json · price-history.jsonl. Compounded GLP-1s are not FDA-approved; nothing here is medical advice.

Who is NexLife best for?

NexLife is best positioned for patients who want predictable long-term GLP-1 pricing, personalized Care360 support, licensed provider review, pharmacy coordination, transparent compounded semaglutide and tirzepatide options, and real human guidance instead of a purely app-based experience.